BeyondSpring Inc.

NASDAQ:BYSI

Biotechnology

Healthcare
$1.25 +1.58%

+$0.03 today

Market cap
$51.40M
Beta
0.42
P/E (TTM)
-8.7
EPS (TTM)
-$0.19
52W Low $1.18High $3.28

Volume 0.01M

Average 0.02M

BYSI Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

BeyondSpring Inc.NASDAQ: BYSI

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables grows, but more slowly than its trailing trend

Q1 FY2026 accounts payables of $4.15M rose 17960.9% year over year, behind the +18711.7% change in trailing-twelve-month accounts payables. Sequentially, it rose 5416.7% from the prior quarter. Over 3 fiscal years it compounded at -49.1% a year.

Context

  • Accounts payables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +17960.9% toward the trailing-twelve-month pace of +18711.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.15M+5416.7% QoQ
Last fiscal yearDec 2025
-$76K— YoY
LTMMar 2026
$4.33M+18711.7% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+17960.9%——
1 year———
3-year CAGR-49.1%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(76K) USD
Year-over-year change
—

Accounts Payables vs competitors

How BYSI compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +18711.7% is the highest of 7, against a peer median of -75.9%.
  • Over three fiscal years its annual growth of -49.1% compares with a peer median of -31.7%.
BYSI Competitors
Accounts Payables for BYSI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BYSIBeyondSpring Inc.LTM Mar 2026$4.33M USD+18711.7%-49.1%—
ATYRaTyr Pharma, Inc.LTM Mar 2026$4M USD-26.3%—2106.8%
BMEABiomea Fusion, Inc.LTM Mar 2026$3.1M USD-201.8%——
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$1.01M USD-157.4%——
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$421K USD——10.7%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$233K USD-91.2%-54.6%—
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$170K USD-60.6%——
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$131.02K CAD—-8.7%0.7%
DTILPrecision BioSciences, Inc.LTM Mar 2026$17K USD+117.0%—0.0%
Peer median (excluding BYSI) —-75.9%-31.7%5.7%

Competitors are the stored peer set for BYSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(68.21M)(36.28M)(21.03M)(11.12M)(8.47M)
Depreciation & Amortization61K232K302K285K87K
Deferred Income Tax(1.2M)0000
Stock-Based Compensation3.15M1.67M554K2.06M0
Change in Working Capital18.41M6.41M2.71M(1.38M)(376K)
Accounts Receivables(1.77M)0000
Inventory1.77M0186K(19K)(18K)
Accounts Payables(560K)(575K)00(76K)
Other Working Capital18.97M6.98M2.52M(1.36M)(282K)
Other Non-Cash Items546K(178K)988K(6.29M)(11.26M)
Operating Cash Flow(47.24M)(28.15M)(16.47M)(16.44M)(20.02M)
Capital Expenditures(2.84M)(34K)(100K)(224K)(50K)
Acquisitions (Net)20.41M00010.05M
Purchases of Investments(44.23M)(32.2M)00(14.95M)
Sales of Investments26.66M49.76M0018.43M
Other Investing Activities(20.41M)717K0(11.79M)0
Investing Cash Flow(20.41M)18.25M(100K)(12.01M)13.48M
Debt Repayment0(1.57M)03.91M286K
Common Stock Issued39K0001.99M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(38K)5M4K22.87M0
Financing Cash Flow1K3.43M4K26.79M2.27M
Effect of Forex Changes(258K)(756K)(76K)(33K)9.13M
Net Change in Cash(67.91M)(7.23M)(16.65M)(1.7M)4.86M
Free Cash Flow(50.09M)(28.19M)(16.57M)(16.67M)(20.07M)

BeyondSpring Inc.

NASDAQ:BYSI

Intrinsic Alpha fair value

Locked

Current Price

$1.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.